Skip to main content
Matt Marinkovich, MD, Dermatology, Redwood City, CA

MattPeterMarinkovichMD

Dermatology Redwood City, CA

Associate Professor, Dermatology, Stanford University School of Medicine

Dr. Marinkovich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Marinkovich's full profile

Already have an account?

  • Office

    Department of Dermatology, Stanford University School of Medicine
    455 Broadway St.
    Redwood City, CA 94063

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Dermatology, 1991 - 1994
  • University of California (San Francisco)/Fresno
    University of California (San Francisco)/FresnoInternship, Internal Medicine, 1988 - 1989
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - 2026
  • OR State Medical License
    OR State Medical License 1989 - 1996
  • American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Journal Articles

  • In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial  
    Gurevich, I. Agarwal, P. Zhang, P. Dolorito, J. A. Oliver, S. Liu, H. Reitze, N. Sarma, N. Bagci, I. S. Sridhar, K. Kakarla, V. Yenamandra, V. K. O'Malley, M. Prisco, ..., Nature Medicine, 3/30/2022
  • Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa  
    Guide, S. V. Gonzalez, M. E. Bagci, I. S. Agostini, B. Chen, H. Feeney, G. Steimer, M. Kapadia, B. Sridhar, K. Quesada Sanchez, L. Gonzalez, F. Van Ligten, M. Parry, T..., New England Journal of Medicine, 12/15/2022